Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients

about

Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients

Item

http://www.wikidata.org/entity/Q24202622

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients

@ast

Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients

@en

Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients

@en-gb

Positron emission tomography

@nl

type

Item

label

Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients

@ast

Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients

@en

Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients

@en-gb

Positron emission tomography

@nl

prefLabel

Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients

@ast

Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients

@en

Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients

@en-gb

Positron emission tomography

@nl

P1476

Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients

@en

P2093

Bastian von Tresckow

http://www.w3.org/2001/XMLSchema#string

Carsten Kobe

http://www.w3.org/2001/XMLSchema#string

Marie-Therese Sickinger

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Practical methods for incorporating summary time-to-event data into meta-analysis

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's

Lestaurtinib inhibition of the Jak/STAT signaling pathway in hodgkin lymphoma inhibits proliferation and induces apoptosis

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.

Epidemiology and etiology of Hodgkin's lymphoma.

P31

scholarly article

P356

10.1002/14651858.CD010533

http://www.w3.org/2001/XMLSchema#string

P50

Nicole Skoetz

Andreas Engert

P577

2013-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime